Skip to main content

30 Day All-cause Risk Standardized Mortality Odds Ratio following Transcatheter Aortic Valve Replacement (TAVR).

CBE ID
3534
Endorsed
New or Maintenance
Is Under Review
No
Measure Description

This measure estimates hospital risk standardized odds ratio for death from all causes within 30 days following transcatheter aortic valve replacement. The measure uses clinical data available in the STS/ACC TVT Registry for risk adjustment. For the purpose of development and testing, the measure used site-reported 30-day follow-up data contained in the STS/ACC TVT Registry.

  • Measure Type
    Electronic Clinical Quality Measure (eCQM)
    Level Of Analysis
    Data dictionary not attached
    No
    Numerator

    The outcome of this measure is all-cause death within 30 days following a transcatheter aortic valve replacement (TAVR).

    Denominator

    The target population for the outcome is for individuals who have undergone transcatheter aortic valve replacement. 

    For development, reassessment and reporting of this measure, we use site reported data from the STS/ACC TVT Registry.

    Exclusions

    1) Hospitals need to meet eligibility criteria to be included in the measure.

    2) Patients are excluded if:
    a) They did not have a first-time TAVR in the episode of care (admission),
    b) The TAVR was subsequent to another procedure in the Registry (other TAVR, Mitral Leaflet Clip and/or TMVR) during that admission.
    c) The patient is readmitted for a repeat TAVR (re-admission) and the initial TAVR was performed during the rolling 3-year timeframe for the measure.
    d) 30-day mortality status missing.

    All information required to stratify the measure results
    Off
    All information required to stratify the measure results
    Off
  • Risk Adjustment
    Risk adjustment approach
    Off
    Risk adjustment approach
    Off
    Conceptual model for risk adjustment
    Off
    Conceptual model for risk adjustment
    Off
  • Most Recent Endorsement Activity
    Endorsed Cardiovascular Fall Cycle 2019
    Initial Endorsement
    Next Planned Maintenance Review
    Fall 2024
    Endorsement Status
    Last Updated
  • Do you have a secondary measure developer point of contact?
    Off
    The measure developer is NOT the same as measure steward
    Off
    Steward Organization Email
    Steward Organization Copyright

    American College of Cardiology Foundation All Rights Reserved

  • Detailed Measure Specifications
    No
    Logic Model
    Off
    Impact and Gap
    No
    Feasibility assessment methodology and results
    No
    Address health equity
    No
    Measure’s use or intended use
    No
    508 Compliance
    Off